FBT.L vs. EMXC
Compare and contrast key facts about First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) and iShares MSCI Emerging Markets ex China ETF (EMXC).
FBT.L and EMXC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FBT.L is a passively managed fund by First Trust that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on May 27, 2020. EMXC is a passively managed fund by iShares that tracks the performance of the MSCI Emerging Markets ex China Index. It was launched on Jul 19, 2017. Both FBT.L and EMXC are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
FBT.L vs. EMXC - Performance Comparison
Loading graphics...
FBT.L vs. EMXC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
FBT.L First Trust NYSE Arca Biotechnology UCITS ETF Acc | -1.95% | 17.24% | 7.13% | -0.99% | 3.88% | -2.57% | -2.54% |
EMXC iShares MSCI Emerging Markets ex China ETF | 11.23% | 25.51% | 4.47% | 13.01% | -10.00% | 9.56% | 25.38% |
Different Trading Currencies
FBT.L is traded in GBp, while EMXC is traded in USD. To make them comparable, the EMXC values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, FBT.L achieves a -1.95% return, which is significantly lower than EMXC's 11.23% return.
FBT.L
- 1D
- 1.48%
- 1M
- -0.46%
- YTD
- -1.95%
- 6M
- 11.21%
- 1Y
- 17.51%
- 3Y*
- 6.78%
- 5Y*
- 5.26%
- 10Y*
- —
EMXC
- 1D
- 0.87%
- 1M
- -6.57%
- YTD
- 11.23%
- 6M
- 20.98%
- 1Y
- 44.32%
- 3Y*
- 17.38%
- 5Y*
- 9.36%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBT.L vs. EMXC - Expense Ratio Comparison
FBT.L has a 0.60% expense ratio, which is higher than EMXC's 0.49% expense ratio.
Return for Risk
FBT.L vs. EMXC — Risk / Return Rank
FBT.L
EMXC
FBT.L vs. EMXC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) and iShares MSCI Emerging Markets ex China ETF (EMXC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBT.L | EMXC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.82 | 2.36 | -1.54 |
Sortino ratioReturn per unit of downside risk | 1.31 | 3.05 | -1.75 |
Omega ratioGain probability vs. loss probability | 1.15 | 1.46 | -0.30 |
Calmar ratioReturn relative to maximum drawdown | 1.14 | 3.72 | -2.58 |
Martin ratioReturn relative to average drawdown | 2.59 | 14.03 | -11.45 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBT.L | EMXC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.82 | 2.36 | -1.54 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.33 | 0.65 | -0.32 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.20 | 0.42 | -0.22 |
Correlation
The correlation between FBT.L and EMXC is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
FBT.L vs. EMXC - Dividend Comparison
FBT.L has not paid dividends to shareholders, while EMXC's dividend yield for the trailing twelve months is around 2.57%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBT.L First Trust NYSE Arca Biotechnology UCITS ETF Acc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EMXC iShares MSCI Emerging Markets ex China ETF | 2.57% | 2.82% | 2.69% | 1.83% | 2.85% | 1.78% | 1.45% | 3.25% | 2.63% | 0.99% |
Drawdowns
FBT.L vs. EMXC - Drawdown Comparison
The maximum FBT.L drawdown since its inception was -30.39%, smaller than the maximum EMXC drawdown of -32.24%. Use the drawdown chart below to compare losses from any high point for FBT.L and EMXC.
Loading graphics...
Drawdown Indicators
| FBT.L | EMXC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.39% | -42.81% | +12.42% |
Max Drawdown (1Y)Largest decline over 1 year | -13.81% | -14.41% | +0.60% |
Max Drawdown (5Y)Largest decline over 5 years | -23.70% | -28.91% | +5.21% |
Current DrawdownCurrent decline from peak | -7.94% | -9.89% | +1.95% |
Average DrawdownAverage peak-to-trough decline | -13.73% | -10.35% | -3.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.08% | 3.46% | +2.62% |
Volatility
FBT.L vs. EMXC - Volatility Comparison
The current volatility for First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) is 7.17%, while iShares MSCI Emerging Markets ex China ETF (EMXC) has a volatility of 9.29%. This indicates that FBT.L experiences smaller price fluctuations and is considered to be less risky than EMXC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBT.L | EMXC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.17% | 9.29% | -2.12% |
Volatility (6M)Calculated over the trailing 6-month period | 14.82% | 14.72% | +0.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.94% | 18.90% | +3.04% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.53% | 14.47% | +8.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.00% | 18.26% | +5.74% |